Drug Shortage Report for CYESTRA-35
Report ID | 107179 |
Drug Identification Number | 02290308 |
Brand name | CYESTRA-35 |
Common or Proper name | Cyproterone acetate and ethinyl estradiol tablets |
Company Name | PALADIN PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL CYPROTERONE ACETATE |
Strength(s) | 0.035MG 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 21 tabs blister |
ATC code | G03HB |
ATC description | ANTIANDROGENS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-02-20 |
Estimated end date | 2020-04-02 |
Actual end date | 2020-04-02 |
Shortage status | Resolved |
Updated date | 2020-04-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-04-03 | English | Compare |
v6 | 2020-04-02 | French | Compare |
v5 | 2020-04-02 | English | Compare |
v4 | 2020-04-01 | French | Compare |
v3 | 2020-04-01 | English | Compare |
v2 | 2020-02-25 | French | Compare |
v1 | 2020-02-25 | English | Compare |
Showing 1 to 7 of 7